Filter
1357
Filtered Results: 1357
Text search:
Li,
J.T
Featured
Recommendations
126
New Publications
204
Language
Document type
No document type
541
Studies & Reports
339
Guidelines
304
Manuals
61
Fact sheets
45
Strategic & Response Plan
29
Training Material
21
Situation Updates
7
Infographics
6
Brochures
3
Resource Platforms
1
Countries / Regions
Global
67
Russia
50
Brazil
38
Latin America and the Carribbean
34
Senegal
24
Germany
24
Western and Central Europe
23
India
23
Congo, Democratic Republic of
22
Syria
19
Kenya
18
Africa
18
Middle East and North Africa
18
Eastern Europe
15
Burkina Faso
14
Yemen
14
Ukraine
13
Peru
12
Haiti
12
Eastern Europe and Central Asia
12
South Africa
12
Ethiopia
12
Rwanda
11
Cameroon
11
Mozambique
11
Asia
11
Indonesia
11
Benin
10
Nigeria
10
West and Central Africa
9
Ecuador
9
Colombia
8
Chile
8
Nepal
7
Malawi
7
Venezuela
7
Tanzania
7
Spain
7
Argentina
7
Bangladesh
7
Philippines
6
South–East Asia Region
6
East and Southern Africa
6
Vietnam
6
Uganda
6
Angola
6
Myanmar / Burma
6
Madagascar
6
Lesotho
5
Sierra Leone
5
China
5
Italy
5
Mali
5
Zambia
5
Ghana
4
Guinea
4
Guinea-Bissau
4
France
4
Côte d’Ivoire / Ivory Coast
4
South Sudan
4
Thailand
3
Togo
3
Cambodia
3
Paraguay
3
Sudan
3
Central African Republic
3
Chad
3
Iraq
3
Tajikistan
2
Kazakhstan
2
Laos
2
Niger
2
Zimbabwe
2
Morocco
2
Qatar
2
USA
2
Saudi Arabia
2
North America
2
Jamaica
2
Portugal
2
Bolivia
2
Honduras
2
Somalia
2
Liberia
2
Switzerland
1
Mexico
1
El Salvador
1
Turkey
1
Canada
1
Congo-Brazzaville
1
Afghanistan
1
Austria
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Jordan
1
Western Pacific Region
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Latvia
1
Lebanon
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Egypt
1
Romania
1
Libya
1
Botswana
1
Eswatini/ Swaziland
1
Cuba
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
429
Clinical Guidelines
120
Public Health
79
Women & Child Health
58
Key Resources
26
Capacity Building
11
Pharmacy & Technologies
10
Toolboxes
COVID-19
310
Mental Health
133
Planetary Health
83
HIV
79
TB
68
NCDs
44
Disability
37
Caregiver
34
NTDs
34
Rapid Response
30
AMR
30
Refugee
27
Global Health Education
22
Ebola
20
Pharmacy
20
Health Financing Toolbox
17
Zika
17
Conflict
12
Natural Hazards
11
Cholera
7
Specific Hazards
6
Polio
4
Social Ethics
3
La santé environnementale est-elle l'avenir de la santé publique ? Cette question qui ne se posait pas il y a encore quelques décennies, prend tout son sens au regards du contexte actuel.
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
En 2006, la session extraordinaire des ministres de la Santé de l’Union africaine a adopté le Plan d’action de Maputo pour la mise en œuvre du cadre politique continental sur la santé et les droits sexuels et
reproductifs (SDSR), qui a expiré fin 2015. L’objectif était que toutes les pa...
Treatment Recommendations for Adult Inpatients
The WHO Guidance on community mental health services: Promoting person-centred and rights-based approaches document is part of the WHO Guidance and technical packages on community mental health services set of publications. It provides a detailed description of person-centred and human rights-based ...
The Quality Criteria for Health National Adaptation Plans (HNAPs) presents examples of good practice in HNAP development to assist countries in developing a comprehensive, feasible and implementable plan. The criteria are also intended to guide countries in setting the foundation for a long-term ite...
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
Available in English, French, Spanish and Russian from the website https://apps.who.int/iris/handle/10665/344562
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
DHS Working Papers No. 105 - Rwanda has developed and implemented many strategies at the national level to reduce the incidence of HIV in the general population. One of the main objectives of such interventions is to improve the general level of knowledge of HIV, with the hypothesis that increasing...
COVID-19: occupational health and safety for health workers: interim guidance, Interim guidance 2 February 2021
Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to different hazards that put them at risk. Occupational hazards include exposure to SARS-C...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
Il vise à guider l ’ élaboration de protocoles cliniques et de politiques sanitaires à l ’ échelle nationale et locale en ce qui concerne les soins au cours de la grossesse dans le contexte de la transmission du virus Zika. Elles n ’ ont pas pour objectif de fournir un guide pratique exhau...
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...
Este documento dá orientações sobre o uso de máscaras na comunidade durante a assistência domiciliar e em serviços de saúde em regiões que têm relatado casos de COVID-19. É dirigido a indivíduos na comunidade, profissionais de saúde pública e de prevenção e controle de infecção (PCI...
Esta é a primeira edição da orientação sobre estratégias de prevenção e controle de infecções (PCI) que devem ser aplicadas quando houver suspeita de COVID-19. Ela foi adaptada do documento da OMS sobre prevenção e controle de infecções durante prestação de cuidados de saúde para ca...
Mund-Nasen-Bedeckung im öffentlichen Raum als weitere Komponente zur Reduktion der Übertragungen von COVID-19. Strategieergänzungen zu empfohlenen Schutzmaßnahmen und Zielen (3. Update) Das RKI empfiehlt ein generelles Tragen einer Mund-Nasen-Bedeckung (MNB) in bestimmten Situationen im öffentl...
